Zydus Lifesciences gets USFDA nod for generic drug
New Delhi, Oct 3: Zydus Lifesciences on Monday said it has received the USFDA’s final nod to market its generic version of Mirabegron extended-release tablets used to treat overactive bladder, with 180 days of shared…
